je.st
news
Home
› NGM And Merck Announce Broad Strategic Collaboration To Discover, Develop And Commercialize Novel Biologic Therapeutics
NGM And Merck Announce Broad Strategic Collaboration To Discover, Develop And Commercialize Novel Biologic Therapeutics
2015-03-04 04:25:06| drugdiscoveryonline News Articles
NGM Biopharmaceuticals, Inc., a privately-held biotechnology company and Merck, known as MSD outside the United States and Canada, recently announced they have entered into a multi-year collaboration to research, discover, develop and commercialize novel biologic therapies across a wide range of therapeutic areas
Tags: develop
broad
discover
collaboration
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||